MabVax Therapeutics Announces The Closing Of $1.3 Million Registered Direct Offering And Is Engaging An Advisory Bank To Explore Strategic Alternatives - BioLegacy Research

MabVax Therapeutics Announces The Closing Of $1.3 Million Registered Direct Offering And Is Engaging An Advisory Bank To Explore Strategic Alternatives

Post author:Sam
Post published:August 22, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace